News from
Immunotherapy Effective in Seniors Despite Immune Changes
2025-05-13 17:45:04| Spiritual Career Counseling
Johns Hopkins Medicine Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy , and the Johns Hopkins Convergence Institute . The study was supported in part by the National Institutes of Health, including the National Cancer Institute's Specialized Programs of Research Excellence.Most new solid tumor cancer diagnoses happen in people ages 65 or older , and overall, these patients have worse cancer treatment outcomes than their younger peers. The reasons for these differences are not entirely clear. Age-related changes that make the immune system less effective could make it harder for patients' immune systems to fight cancer cells. Newer immune system-boosting therapies may help, but questions remain about whether age-related immune changes might blunt the dr...
Category:
Employment